Lipid News

Flipping lipids to deform membranes

Naoto Takada Tomoki  Naito Hye-Won  Shin
By Naoto Takada, Tomoki Naito and Hye-Won Shin
Jan. 7, 2020

Cell membranes change shape during such functions as membrane trafficking, cell migration and cell division. Rearrangement of cytoskeletons and interactions of various proteins, including membrane-bending proteins, regulate these changes. When the composition and asymmetric distribution of lipids between the two leaflets of the membrane bilayer change, membranes are deformed, a requirement for processes such as immune response and nutrient uptake. 

Jan19lipidnews.jpg
Hye-Won Shin
The chemically induced dimerization system allows recruitment of BAR domains to the plasma membrane upon treatment with rapamycin (top). BAR domains can generate membrane tubulation following induction of membrane deformation by P4-ATPases.

In mammalian cells, the phospholipids phosphatidylserine and phosphatidylethanolamine are abundant in the cytoplasmic leaflet of the bilayer, whereas phosphatidylcholine, or PC, and sphingomyelin are abundant in the exoplasmic leaflet. P4-ATPases, also called flippases, catalyze unidirectional flipping of lipid molecules from the exoplasmic to the cytoplasmic leaflets of the bilayer and are crucial for membrane trafficking, but we don’t know how they are coupled to the process of vesicle formation. 

P4-ATPase–mediated phospholipid translocation might cause an imbalance of lipid mass between the leaflets of the bilayer, so our lab wanted to find out whether the flipping enzymes of the P4-ATPase family contribute to changes in the shape of cell membranes. PC is abundant in the outer leaflet, so we hypothesized that greater PC-flipping activity causes an increase in lipid mass in the inner leaflet of the plasma membrane and induces inward membrane curvature.

To test this hypothesis, we used BIN/Amphiphysin/Rvs, or BAR, domains, which can sense membrane curvature and induce tubular membrane structures via self-oligomerization. We examined plasma membrane-bending caused by BAR domains with a rapamycin-inducible dimerization system, using FK506 binding proteins, or FKBPs, and FKBP–rapamycin binding domain, or FRB, proteins, that allow for acute recruitment of BAR domains to the plasma membrane. FRB was targeted to the plasma membrane by adding the N-terminal 11 amino acids of Lyn kinase, and FKBP was fused to the BAR domain.

When one specific BAR domain, called N-BAR, is recruited to the plasma membrane, we know that it penetrates the lipid bilayer via its N-terminal amphipathic helix, causing a small inward curve to form. The protein senses this change in curvature, leading to the recruitment of more N-BAR domains, which oligomerize along a part of the membrane and trigger transformation of the membrane into a tube.

Delta-N-BAR (which lacks the N-terminal amphipathic helix of the N-BAR domain) and F-BAR domains did not do this unless ATP10A was expressed exogenously in cells. In 2015, we had published in the Journal of Biological Chemistry our finding that ATP10A flipped PC from the outer to the inner leaflet of the plasma membrane, slightly changing the shape of the plasma membrane. Delta-N-BAR and F-BAR domains sensed the change and bound to the plasma membrane. The proteins then oligomerized along the membrane and transformed that part of the membrane into an inwardly protruding tubule.

Our recent study shows that changes in the transbilayer lipid compositions induced by P4-ATPase can deform biological membranes. Increased inward plasma membrane bending by ATP10A expression enhances endocytosis. The plasma membrane also changes shape during cell migration, cancer cell invasion, cell division, nutrient uptake and entry of pathogens into cells, so lipid-flipping activity may be involved in any or all of these processes.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition weekly.

Learn more
Naoto Takada
Naoto Takada

Naoto Takada received his master’s degree in the Shin lab in the Graduate School of Pharmaceutical Sciences at Kyoto University, Japan. He now works at a private enterprise in Japan.

Tomoki  Naito
Tomoki Naito

Tomoki Naito received his Ph.D. in the Shin lab. He is now a postdoctoral fellow in Yasunori Saheki’s laboratory in Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.

Hye-Won  Shin
Hye-Won Shin

Hye-Won Shin is an associate professor of the Graduate School of Pharmaceutical Sciences at Kyoto University, Japan.
 

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Guiding grocery carts to shape healthy habits
Award

Guiding grocery carts to shape healthy habits

Nov. 21, 2024

Robert “Nate” Helsley will receive the Walter A. Shaw Young Investigator in Lipid Research Award at the 2025 ASBMB Annual Meeting, April 12–15 in Chicago.

Quantifying how proteins in microbe and host interact
Journal News

Quantifying how proteins in microbe and host interact

Nov. 20, 2024

“To develop better vaccines, we need new methods and a better understanding of the antibody responses that develop in immune individuals,” author Johan Malmström said.

Leading the charge for gender equity
Award

Leading the charge for gender equity

Nov. 19, 2024

Nicole Woitowich will receive the ASBMB Emerging Leadership Award at the 2025 ASBMB Annual meeting, April 12–15 in Chicago.

CRISPR gene editing: Moving closer to home
News

CRISPR gene editing: Moving closer to home

Nov. 17, 2024

With the first medical therapy approved, there’s a lot going on in the genome editing field, including the discovery of CRISPR-like DNA-snippers called Fanzors in an odd menagerie of eukaryotic critters.

Finding a missing piece for neurodegenerative disease research
News

Finding a missing piece for neurodegenerative disease research

Nov. 16, 2024

Ursula Jakob and a team at the University of Michigan have found that the molecule polyphosphate could be what scientists call the “mystery density” inside fibrils associated with Alzheimer’s, Parkinson’s and related conditions.

From the journals: JLR
Journal News

From the journals: JLR

Nov. 15, 2024

Enzymes as a therapeutic target for liver disease. Role of AMPK in chronic liver disease Zebrafish as a model for retinal dysfunction. Read about the recent JLR papers on these topics.